CoMind manufactures optical brain-monitoring hardware paired with an AI platform (CoVision) for real-time physiological signal inference in clinical settings. The tech stack reveals a hardware-first organization: FPGA design (Xilinx, Vivado, Verilog, VHDL), optical characterization (Altium Designer, JESD204B signaling), and embedded C/C++/CUDA—typical of companies building medical-grade sensor systems. Active pain points center on clinical deployment and regulatory pathways, not technology scaling, indicating the bottleneck is field validation and FDA submissions rather than R&D velocity.
CoMind designs and manufactures non-invasive brain monitoring devices that measure brain activity using optical imaging technology. The company operates across intensive care, surgery, and emergency medicine, positioning CoVision as a decision-support tool for clinicians to anticipate complications. Founded in 2018 and based in London, CoMind employs 51–200 people and is privately held with backing from Octopus Ventures, LocalGlobe, Angelini Ventures, and Crane Venture Partners. Current hiring spans data science, engineering, healthcare, and research roles, with a lean workforce structure typical of early-stage medtech firms navigating FDA pathways and clinical adoption.
Python, C++, CUDA for compute; Xilinx/Zynq FPGA tooling (Vivado, Verilog, VHDL) for hardware; Altium Designer for PCB; Azure AD and FortiGate for infrastructure; Jira, Confluence, Bitbucket for collaboration.
R&D across optical components, signal processing, and machine learning for cerebral blood flow monitoring; medical-grade software for FDA regulatory pathways; ML model architecture validation; clinical data analysis and physiological signal inference.
Other companies in the same industry, closest in size
CoMind's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.